Mrs Gail Ann Rattigan, FNP | |
56 N Pecos Rd, Henderson, NV 89074-7331 | |
(702) 877-5199 | |
Not Available |
Full Name | Mrs Gail Ann Rattigan |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 23 Years |
Location | 56 N Pecos Rd, Henderson, Nevada |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104045178 | NPI | - | NPPES |
100509174 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | APN683 (Nevada) | Secondary |
363L00000X | Nurse Practitioner | APRN000683 (Nevada) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Optum Medical Group Ii Rhodes P C | 4981687779 | 318 |
News Archive
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study led by researchers from Icahn School of Medicine at Mount Sinai presented November 18 at the American Heart Association Scientific Sessions 2014 in Chicago, IL.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
It's time patient consent forms came back full circle to a tool for patient education, rather than the waiver of liability they have become.
NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.
› Verified 3 days ago
Entity Name | Southwest Medical Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659346005 PECOS PAC ID: 6103730544 Enrollment ID: O20031118001102 |
News Archive
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study led by researchers from Icahn School of Medicine at Mount Sinai presented November 18 at the American Heart Association Scientific Sessions 2014 in Chicago, IL.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
It's time patient consent forms came back full circle to a tool for patient education, rather than the waiver of liability they have become.
NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.
› Verified 3 days ago
Entity Name | Optum Medical Group Ii Rhodes P C |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770556037 PECOS PAC ID: 4981687779 Enrollment ID: O20040611000770 |
News Archive
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study led by researchers from Icahn School of Medicine at Mount Sinai presented November 18 at the American Heart Association Scientific Sessions 2014 in Chicago, IL.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
It's time patient consent forms came back full circle to a tool for patient education, rather than the waiver of liability they have become.
NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Gail Ann Rattigan, FNP Po Box 35380, Las Vegas, NV 89133-5380 Ph: (702) 877-5199 | Mrs Gail Ann Rattigan, FNP 56 N Pecos Rd, Henderson, NV 89074-7331 Ph: (702) 877-5199 |
News Archive
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study led by researchers from Icahn School of Medicine at Mount Sinai presented November 18 at the American Heart Association Scientific Sessions 2014 in Chicago, IL.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
It's time patient consent forms came back full circle to a tool for patient education, rather than the waiver of liability they have become.
NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.
› Verified 3 days ago
Lydia Glaude, PHD, RN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2662 W Horizon Ridge Pkwy, Henderson, NV 89052 Phone: 702-616-9660 | |
Mrs. Edith Lamira Odiwo, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2200 Paseo Verde Pkwy Ste 190, Henderson, NV 89052 Phone: 702-589-4871 Fax: 702-589-4872 | |
Martha Kim, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9065 S Pecos Rd Ste 190, Henderson, NV 89074 Phone: 702-888-3148 | |
Crystal Celeste Huffaker, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1655 W Horizon Ridge Pkwy, Henderson, NV 89012 Phone: 702-476-9999 Fax: 702-946-1343 | |
Ms. Markquetta Renee Jackson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2200 Paseo Verde Pkwy Ste 190, Henderson, NV 89052 Phone: 702-589-4871 | |
Odelaysis Padron-oramas, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 W Sunset Rd Ste 102, Henderson, NV 89011 Phone: 725-241-5252 Fax: 725-231-7474 | |
Natalie Mason, MSN, RN, PNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2350 W Horizon Ridge Pkwy, Henderson, NV 89052 Phone: 702-564-8556 Fax: 702-564-4485 |